Psoriasis risk after beta‐blocker exposure: Description of a pharmacovigilance signal-Reference-Cited by-同舟云学术

Psoriasis risk after beta‐blocker exposure: Description of a pharmacovigilance signal

Published:2022-04-06 Issue:8 Volume:88 Page:3813-3818
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Azzouz Brahim¹²^ORCID,De Guizelin Apolline¹,Lambert Aude³,Fresse Audrey⁴,Morel Aurore¹,Trenque Thierry¹²^ORCID

Affiliation:

1. Regional Centre of Pharmacovigilance and Pharmacoepidemiology Reims University Hospital Reims France

2. EA 3797 Vieillissement, Fragilité, Faculty of Medicine University of Reims Champagne‐Ardenne Reims France

3. Regional Pharmacovigilance Centre Strasbourg University Hospital Strasbourg France

4. Regional Pharmacovigilance Centre Nancy University Hospital Nancy France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15330

Reference31 articles.

1. A systematic review of worldwide epidemiology of psoriasis

2. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

3. Drug-Induced Psoriasis

4. Psoriasis Induced or Aggravated by Drugs

5. Drug‐provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance;Kim GK;J Clin Aesthetic Dermatol,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardio-Rheumatology Insights Into Hypertension: Intersection of Inflammation, Arteries, and Heart;American Journal of Hypertension;2024-07-26

2. Etiopathogenesis of Psoriasis: Integration of Proposed Theories;Immunological Investigations;2024-01-19

3. Causes of Autoimmune Psoriasis and Associated Cardiovascular Disease: Roles of Human Endogenous Retroviruses and Antihypertensive Drugs—A Systematic Review and Meta-analysis;2023-11-24

4. Histamine H2 receptor antagonist exhibited comparable all-cause mortality-decreasing effect as β-blockers in critically ill patients with heart failure: a cohort study;Frontiers in Pharmacology;2023-11-13

5. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension;Journal of Hypertension;2023-09-26